CORMEDIX INC. - COMMON STOCK

CorMedix Announces Collaboration for DefenCath Promotion to the VA and Other Federal Facilities

21 يناير 2025 08:00:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update

07 يناير 2025 07:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Added to Nasdaq Biotechnology Index

19 ديسمبر 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products

26 نوفمبر 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium

04 نوفمبر 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update

30 أكتوبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Announces New Data at ASN Kidney Week 2024

24 أكتوبر 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024

23 أكتوبر 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Announces New Commercial Agreement with Mid-Sized Dialysis Operator

08 أكتوبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Announces New Commercial Agreement

19 سبتمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. to Present at the Cantor Global Healthcare Conference

13 سبتمبر 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Announces New Commercial Agreement

09 سبتمبر 2024 10:52:30 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update

14 أغسطس 2024 07:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 14, 2024

07 أغسطس 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Announces Outpatient Availability of DefenCath

03 يوليو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Receives FDA Feedback on Potential Label Expansion

18 يونيو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath

06 يونيو 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. to Participate in Two Upcoming Investor Conferences

10 مايو 2024 08:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

09 مايو 2024 07:30:00 بحسب Nasdaq GlobeNewswire

CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024

06 مايو 2024 08:30:00 بحسب Nasdaq GlobeNewswire